CH
HUMAW icon

CVI Holdings’s Humacyte Inc Warrant HUMAW Stock Holding History

CVI Holdings’s Portfolio HUMAW Stock Details HUMAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,802
Closed -$7.82K – 167
2023
Q4 		$7.82K Sell
18,802
-37,614
-67% -$18.5K 0.02% 99
2023
Q3 		$40.5K Sell
56,416
-19,112
-25% -$14.9K 0.08% 65
2023
Q2 		$49.2K Sell
75,528
-88,244
-54% -$71.3K 0.05% 81
2023
Q1 		$98.3K Sell
163,772
-35,040
-18% -$20.9K 0.04% 154
2022
Q4 		$78.1K Sell
198,812
-35,118
-15% -$31K 0.01% 291
2022
Q3 		$257K Sell
233,930
-10,895
-4% -$12K 0.02% 429
2022
Q2 		$218K Sell
244,825
-24,313
-9% -$37.3K 0.02% 465
2022
Q1 		$517K Sell
269,138
-22,694
-8% -$38.3K 0.03% 453
2021
Q4 		$665K Buy
291,832
+107,982
+59% +$316K 0.04% 418
2021
Q3 		$544K Buy
183,850
+114,986
+167% +$337K 0.03% 417
2021
Q2 		$193K Hold
68,864
– – 0.01% 484
2021
Q1 		$206K Buy
+68,864
New +$163K 0.01% 418

Other funds holding HUMAW

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

CVI Holdings's HUMAW Position: Q1 2024 in Review

CVI Holdings sold out of Humacyte Inc Warrant (HUMAW) in Q1 2024, closing a stake of 18,802 shares — an estimated $7.82K sold.

CVI Holdings first reported a position in HUMAW in Q1 2021 and held it in 12 quarters. The position peaked at $665K in Q4 2021. 6 funds tracked by Wall St. Rank hold HUMAW as of Q1 2024.

  • CVI Holdings reported no remaining Humacyte Inc Warrant position as of Q1 2024 after selling out during the quarter.
  • CVI Holdings sold 18,802 Humacyte Inc Warrant shares in Q1 2024, an estimated $7.82K.
  • CVI Holdings first reported a position in Humacyte Inc Warrant in Q1 2021 and held it in 12 quarters.
  • CVI Holdings's Humacyte Inc Warrant position peaked at $665K in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q1 2024.

Based on CVI Holdings's 13F filing for Q1 2024, filed 7 May 2024.